CIK 0001813814
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −11,491 | $6.80 | $78K | 305,130 |
| 2025-06-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −7,848 | $6.80 | $53K | 438,329 |
| 2025-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −26,491 | $6.80 | $180K | 830,065 |
| 2025-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −21,208 | $6.74 | $143K | 856,556 |
| 2025-03-25 | Karlin Daniel Chief Medical Officer | Sale 10b5-1 | −6,836 | $6.74 | $46K | 446,177 |
| 2025-03-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −6,576 | $6.74 | $44K | 316,621 |
| 2025-03-25 | Liao Carrie Chief Accounting Officer | Sale 10b5-1 | −2,347 | $6.74 | $16K | 144,923 |
| 2024-12-26 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,106 | $7.43 | $142K | 526,666 |
| 2024-12-26 | Liao Carrie Chief Accounting Officer | Sale 10b5-1 | −2,273 | $7.43 | $17K | 97,270 |
| 2024-12-26 | Karlin Dan Chief Medical Officer | Sale 10b5-1 | −6,643 | $7.43 | $49K | 338,013 |
| 2024-12-26 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −4,519 | $7.43 | $34K | 173,197 |
| 2024-09-25 | Liao Carrie Chief Accounting Officer | Sale 10b5-1 | −2,352 | $5.98 | $14K | 99,543 |
| 2024-09-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −19,771 | $5.98 | $118K | 545,772 |
| 2024-09-25 | Karlin Dan Chief Medical Officer | Sale 10b5-1 | −6,871 | $5.98 | $41K | 344,656 |
| 2024-09-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −4,430 | $5.98 | $26K | 177,716 |
| 2024-06-25 | Sullivan Mark Chief Legal Officer | Sale 10b5-1 | −17,854 | $7.22 | $129K | 182,146 |
| 2024-06-25 | Karlin Dan Chief Medical Officer | Sale 10b5-1 | −6,925 | $7.22 | $50K | 351,527 |
| 2024-06-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −15,659 | $7.22 | $113K | 564,543 |
| 2024-03-25 | Karlin Dan Chief Medical Officer | Sale 10b5-1 | −6,578 | $9.50 | $62K | 358,452 |
| 2024-03-25 | Barrow Robert Chief Executive Officer | Sale 10b5-1 | −16,519 | $9.50 | $157K | 580,202 |
Page 2 of 5 · 82 trades